RADIENT PHARMACEUTICALS Corp Contracts & Agreements
95 Contracts & Agreements
- Business Finance (49 contracts)
- Business Operations (8)
- Human Resources (12)
- Intellectual Property (6)
- Uncategorized (20)
- Onko-Sure DR-70 License Agreement (Filed With SEC on June 18, 2013)
- Onko-Sure DR-70 License Agreement (Filed With SEC on June 11, 2013)
- AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on September 18, 2012)
- AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on August 24, 2012)
- LICENSE AGREEMENT (Filed With SEC on July 17, 2012)
- RADIENT PHARMACEUTICALS CORPORATION 2492 Walnut Avenue, Suite 100 Tustin, CA 92780 (Filed With SEC on May 21, 2012)
- DEBENTURE AMENDMENT (Filed With SEC on February 14, 2012)
- CONSULTING AGREEMENT For Investor Relations Services BETWEEN (Filed With SEC on February 14, 2012)
- AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on February 14, 2012)
- CONSULTING AGREEMENT For Investor Relations Services BETWEEN (Filed With SEC on February 14, 2012)
- AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on February 14, 2012)
- Garden State Securities Inc. (Filed With SEC on February 14, 2012)
- AMENDMENT TO ADVISORY AGREEMENT (Filed With SEC on February 14, 2012)
- INVESTMENT ADVISORY AGREEMENTBETWEEN RADIENT PHARMACEUTICALS CORP., AND GALILEO ASSET MANAGEMENT SA (Filed With SEC on February 14, 2012)
- AMENDMENT TO INVESTMENT ADVISORYAGREEMENT (Filed With SEC on February 14, 2012)
- CONSULTING AGREEMENT (Filed With SEC on February 14, 2012)
- AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on February 14, 2012)
- CONSULTING AGREEMENT (Filed With SEC on February 14, 2012)
- AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on February 14, 2012)
- RADIENT PHAMACEUTICALSCORPORATION (Filed With SEC on February 14, 2012)
- Agreement (Filed With SEC on November 29, 2011)
- Agreement (Filed With SEC on November 29, 2011)
- EXCHANGE AGREEMENT (Filed With SEC on November 29, 2011)
- CERTIFICATE OF DESIGNATIONS OF THE SERIES B CONVERTIBLE PREFERRED STOCK OF RADIENT PHARMACEUTICALS CORPORATION (Filed With SEC on November 29, 2011)
- [FORM OF CONVERTIBLE NOTE] (Filed With SEC on November 29, 2011)
- [FORM OF SERIES A WARRANT] RADIENT PHARMACEUTICALS CORPORATION Warrant To Purchase Common Stock (Filed With SEC on November 29, 2011)
- [FORM OF SERIES B WARRANT] RADIENT PHARMACEUTICALS CORPORATION Warrant To Purchase Series C Convertible Preferred Stock (Filed With SEC on November 29, 2011)
- CERTIFICATE OF DESIGNATIONS OF THE SERIES C CONVERTIBLE PREFERRED STOCK OF RADIENT PHARMACEUTICALS CORPORATION (Filed With SEC on November 29, 2011)
- FINAL SETTLEMENT AGREEMENT (Filed With SEC on August 29, 2011)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 29, 2011)
- RELEASE AGREEMENT (Filed With SEC on August 29, 2011)
- Radient Pharmaceuticals Corporation 2492 Walnut Avenue, Suite 100 Tustin, California 92780 (Filed With SEC on August 29, 2011)
- Order (Filed With SEC on August 29, 2011)
- Radient Pharmaceuticals Corporation 2492 Walnut Avenue, Suite 100 Tustin, California 92780 August 26, 2011 (Filed With SEC on August 29, 2011)
- Radient Pharmaceuticals Corporation 2492 Walnut Avenue, Suite 100 Tustin, California 92780 (Filed With SEC on August 2, 2011)
- EXCHANGE AGREEMENT (Filed With SEC on July 1, 2011)
- [FORM OF CONVERTIBLE NOTE] (Filed With SEC on July 1, 2011)
- [FORM OF WARRANT] RADIENT PHARMACEUTICALS CORPORATION Warrant To Purchase Common Stock (Filed With SEC on July 1, 2011)
- Amendment To Settlement Agreement (Filed With SEC on June 8, 2011)
- Exclusive 5-Year Collaboration Agreement RECITALS (Filed With SEC on May 25, 2011)
- www.radient-pharma.com RADIENT PHARMACEUTICALS CORP. EXCLUSIVE DISTRIBUTION AGREEMENT(JAIVA GAUR DIAGNO, TERRITORY: INDIA) (Filed With SEC on May 25, 2011)
- (A Radient Pharmaceutical Subsidiary) AMDL DIAGNOSTICS INC. EXCLUSIVE DISTRIBUTION AGREEMENT (NAROO DITECH INC., TERRITORY: KOREA) (Filed With SEC on May 25, 2011)
- Settlement Agreement (Filed With SEC on May 17, 2011)
- Promissory Note (Filed With SEC on May 17, 2011)
- JADEPHARMACEUTICALS, INC. 10%CONVERTIBLE EXCHANGEABLE DEBENTURE DUE:December__, 20__ (Filed With SEC on February 4, 2011)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on January 31, 2011)
- [FORMOF CONVERTIBLE NOTE] (Filed With SEC on January 31, 2011)
- FORMOF SERIES [A] [B] WARRANT (Filed With SEC on January 31, 2011)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on January 31, 2011)
- EXCHANGEAGREEMENT (Filed With SEC on January 24, 2011)
- EXCHANGEAGREEMENT (Filed With SEC on January 24, 2011)
- RADIENTPHARMACEUTICALS CORPORATION WARRANTTO PURCHASE _______ SHARES OF COMMON STOCK (Filed With SEC on October 8, 2010)
- 2492Walnut Avenue, Ste 100, Tustin, CA 92780 | Office ###-###-#### | Fax714 ###-###-#### Website:www.radient-pharma.com| E-mail ***@*** (Filed With SEC on September 7, 2010)
- EXCHANGE AGREEMENT (Filed With SEC on August 12, 2010)
- - Confidential - William Gartner Douglas MacLellanPresident & CEO Chairman & CEOProvista Diagnostics Inc. Radient Pharmaceuticals Corp.6225 N. 24TH ST. Suite 150 2492 Walnut Ave,... (Filed With SEC on July 12, 2010)
- NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on April 13, 2010)
- RADIENT PHARMACEUTICALS CORPORATION Convertible Promissory Note (Filed With SEC on April 13, 2010)
- RADIENT PHARMACEUTICALS CORPORATION WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on April 13, 2010)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 13, 2010)
- RADIENT PHARMACEUTICALS CORPORATION FINAL ADDENDUM TO NOTE AND WARRANT PURCHASE AGREEMENT DATED:APRIL 8, 2010 (Filed With SEC on April 13, 2010)
- NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on March 26, 2010)
- RADIENT PHARMACEUTICALS CORPORATION Convertible Promissory Note (Filed With SEC on March 26, 2010)
- RADIENT PHARMACEUTICALS CORPORATION WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on March 26, 2010)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 26, 2010)
- No. __________ $______________ Tustin, California [FORMOF REG D NOTE] AMDL,INC. 12%SENIOR PROMISSORY NOTE DUE:_________, 2010 (Filed With SEC on March 16, 2010)
- EXCHANGEAGREEMENT (Filed With SEC on March 16, 2010)
- WAIVER OFDEFAULT (Filed With SEC on March 16, 2010)
- No. __________$______________Tustin, California [FORM OF] AMDL, INC. 12% SERIES2 SENIOR PROMISSORY NOTE DUE: ______________, 2012 (Filed With SEC on December 16, 2009)
- WAIVER OF DEFAULT (Filed With SEC on December 16, 2009)
- WAIVER OF TRIGGER EVENT (Filed With SEC on December 16, 2009)
- 1,644,643 Units RADIENT PHARMACEUTICALS CORPORATION (F/K/A AMDL, INC.) CONSISTING OF COMMON STOCK (PAR VALUE $0.001) AND WARRANTS WITH AN EXERCISE PRICE OF $1.25 PLACEMENT AGENT... (Filed With SEC on December 2, 2009)
- COMMON STOCK PURCHASE WARRANT RADIENT PHARMACEUTICALS CORPORATION Warrant Shares: _______Initial Exercise Date: November __, 2009 (Filed With SEC on December 2, 2009)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 2, 2009)
- NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on September 18, 2009)
- AMDL, Inc. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on September 18, 2009)
- AMDL, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on September 18, 2009)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 18, 2009)
- BRIDGE LOAN AGREEMENT (Filed With SEC on September 18, 2009)
- STOCK PURCHASE WARRANT For the Purchase of 100,000 Shares of Common Stock, $.001 Par Value of AMDL, INC. A Delaware Corporation (Filed With SEC on September 18, 2009)
- AMDL, Inc. 2492 Walnut Ave., Suite 100, Tustin, CA 92780 Phone 714.505.4460FAX ###-###-#### Web site: http://www.amdl.comE-mail address: ***@*** (Filed With SEC on September 18, 2009)
- STOCK PURCHASE WARRANT For the Purchase of 200,000 Shares of Common Stock, $.001 Par Value of AMDL, INC. A Delaware Corporation (Filed With SEC on September 18, 2009)
- Current assets (Filed With SEC on August 19, 2009)
- Current assets (Filed With SEC on August 19, 2009)
- obtain China SFDA, Korean FDA, and Taiwan FDA and other international approvals (Filed With SEC on April 15, 2009)
- obtain China SFDA, Korean FDA, and Taiwan FDA and other international approvals (Filed With SEC on April 15, 2009)
- AMDL, Inc. 2008-2009 PERFORMANCE AND EQUITY INCENTIVE PLAN (Filed With SEC on January 9, 2009)
- SEVERANCE AGREEMENT AND MUTUAL GENERAL RELEASES (Filed With SEC on November 5, 2008)
- PRODUCT LICENSE, DISTRIBUTION AND MANUFACTURING AGREEMENT (Filed With SEC on April 3, 2008)
- AMENDMENT NO. 1 TO ESCROW AGREEMENT (Filed With SEC on March 31, 2008)
- AMENDMENT NO. 2 TO ESCROW AGREEMENT (Filed With SEC on March 31, 2008)
- AMDL, INC. (Filed With SEC on March 31, 2008)
- AMDL, INC. EXECUTIVE MANAGEMENT CHANGE IN CONTROL SEVERANCE PAY PLAN (Filed With SEC on March 31, 2008)
- AMDL, INC (Filed With SEC on November 10, 2005)
- AMDL, INC. EMPLOYMENT AGREEMENT (Filed With SEC on February 1, 2005)
- AMDL, INC. (Registrant) (Filed With SEC on September 17, 2001)
